ICFG Spain acted as exclusive Financial Adviser to Fernandez y Canivell SA in its divestment of its Ceregumil brand to Spanish Pharma Uriach Group.
Dr.-Ing. Guido Siebiera, MBA, is a well-known Healthcare transactions specialist with more than 30 years of international experience in consulting, business development, general management and M&A.
Experience
He has 25 years+ experience as Strategic Consultant, Head of Business Development inside ThyssenKrupp group, CEO of a 400 people company and as M&A Advisor. As M&A Advisor he co-founded the Spanish office of Lincoln International, founded the Spanish office of C.W.Downer&Co. and established successfully the Consumer Health practice of Alantra.
Among his former clients are Daimler, Audi, BASF, Telefonica, Bosch, FCC, Bilfinger, Imtech, Ferrer, Uriach, Cinfa, Lacer as well as private equity funds like American Capital, Apollo Management, 3i and Tagua Capital.
Guido has international experience in Germany, Spain, the UK, Italy, France, the Netherlands and Poland and to a lesser extend in the USA and Brazil. He speaks German, English and Spanish.
Education
Guido holds a PhD in Industrial Engineering from RWTH Aachen as well as an MBA from ESADE Business School and participated in the AMP program of Columbia Business School. Guido was professor for Strategy, Internationalization and M&A at Business Schools in Spain and Germany and is still teaching at IE Business School in Madrid.
Life drives and passions
Golf, music, cinema
ICFG Spain acted as exclusive Financial Adviser to Fernandez y Canivell SA in its divestment of its Ceregumil brand to Spanish Pharma Uriach Group.
| Boltendahl International Partners was hired as exclusive Financial Advisor to Fernandez y Canivell SA for its divestment of its iconic “Ceregumil” healthcare brand and other assets to the pharmaceutical group Uriach in Spain. |
